{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2023,9,8]],"date-time":"2023-09-08T13:19:01Z","timestamp":1694179141525},"reference-count":49,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2006,2,1]],"date-time":"2006-02-01T00:00:00Z","timestamp":1138752000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Naunyn Schmied Arch Pharmacol"],"published-print":{"date-parts":[[2006,2]]},"DOI":"10.1007\/s00210-006-0041-x","type":"journal-article","created":{"date-parts":[[2006,2,20]],"date-time":"2006-02-20T11:03:22Z","timestamp":1140433402000},"page":"335-345","source":"Crossref","is-referenced-by-count":6,"title":["5-HT-stimulated [35S]guanosine-5\u2032-O-(3-thio)triphosphate binding as an assay for functional activation of G proteins coupled with 5-HT1B receptors in rat striatal membranes"],"prefix":"10.1007","volume":"372","author":[{"given":"Yuji","family":"Odagaki","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ryoichi","family":"Toyoshima","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2006,2,21]]},"reference":[{"key":"41_CR1","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1016\/S0893-133X(01)00237-8","volume":"25","author":"V Audinot","year":"2001","unstructured":"Audinot V, Newman-Tancredi A, Cussac D, Millan MJ (2001) Inverse agonist properties of antipsychotic agents at cloned, human (h) serotonin (5-HT)1B and h5-HT1D receptors. Neuropsychopharmacology 25:410\u2013422","journal-title":"Neuropsychopharmacology"},{"key":"41_CR2","doi-asserted-by":"crossref","first-page":"1083","DOI":"10.1016\/S0028-3908(99)00010-6","volume":"38","author":"NM Barnes","year":"1999","unstructured":"Barnes NM, Sharp T (1999) A review of central 5-HT receptors and their function. Neuropharmacology 38:1083\u20131152","journal-title":"Neuropharmacology"},{"key":"41_CR3","doi-asserted-by":"crossref","first-page":"1196","DOI":"10.1111\/j.1476-5381.1993.tb13941.x","volume":"110","author":"MS Beer","year":"1993","unstructured":"Beer MS, Stanton JA, Bevan Y, Heald A, Reeve AJ, Street LJ, Matassa VG, Hargreaves RJ, Middlemiss DN (1993) L-694,247: a potent 5-HT1D receptor agonist. Br J Pharmacol 110:1196\u20131200","journal-title":"Br J Pharmacol"},{"key":"41_CR4","first-page":"225","volume":"5","author":"P Bonaventure","year":"1997","unstructured":"Bonaventure P, Schotte A, Cras P, Leysen JE (1997) Autoradiographic mapping of 5-HT1B- and 5-HT1D receptors in human brain using [3H]alniditan, a new radioligand. Recept Channels 5:225\u2013230","journal-title":"Recept Channels"},{"key":"41_CR5","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/0014-2999(88)90799-6","volume":"151","author":"R Bouhelal","year":"1988","unstructured":"Bouhelal R, Smounya L, Bockaert J (1988) 5-HT1B receptors are negatively coupled with adenylate cyclase in rat substantia nigra. Eur J Pharmacol 151:189\u2013196","journal-title":"Eur J Pharmacol"},{"key":"41_CR6","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1177\/026988119801200305","volume":"12","author":"P Boulenguez","year":"1998","unstructured":"Boulenguez P, Peters SL, Mitchell SN, Chauveau J, Gray JA, Joseph MH (1998) Dopamine release in the nucleus accumbens and latent inhibition in the rat following microinjections of a 5-HT1B agonist into the dorsal subiculum: implications for schizophrenia. J Psychopharmacol 12:258\u2013267","journal-title":"J Psychopharmacol"},{"key":"41_CR7","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1007\/BF00166939","volume":"347","author":"AT Bruinvels","year":"1993","unstructured":"Bruinvels AT, Palacios JM, Hoyer D (1993) Autoradiographic characterisation and localisation of 5-HT1D compared to 5-HT1B binding sites in rat brain. Naunyn-Schmiedeberg\u2019s Arch Pharmacol 347:569\u2013582","journal-title":"Naunyn-Schmiedeberg\u2019s Arch Pharmacol"},{"key":"41_CR8","doi-asserted-by":"crossref","first-page":"2253","DOI":"10.1021\/jm00041a001","volume":"37","author":"JW Clitherow","year":"1994","unstructured":"Clitherow JW, Scopes DIC, Skingle M, Jordan CC, Feniuk W, Campbell IB, Carter MC, Collington EW, Connor HE, Higgins GA, Beattie D, Kelly HA, Mitchell WL, Oxford AW, Wadsworth AH, Tyers MB (1994) Evolution of a novel series of [(N,N-dimethylamino)propyl]- and piperazinylbenzanilides as the first selective 5-HT1D antagonists. J Med Chem 37:2253\u20132257","journal-title":"J Med Chem"},{"key":"41_CR9","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1016\/S0893-133X(99)00164-5","volume":"22","author":"SC Dulawa","year":"2000","unstructured":"Dulawa SC, Gross C, Stark KL, Hen R, Geyer MA (2000) Knockout mice reveal opposite roles for serotonin 1A and 1B receptors in prepulse inhibition. Neuropsychopharmacology 22:650\u2013659","journal-title":"Neuropsychopharmacology"},{"key":"41_CR10","doi-asserted-by":"crossref","first-page":"1258","DOI":"10.1046\/j.1471-4159.1998.70031258.x","volume":"70","author":"DS Dupuis","year":"1998","unstructured":"Dupuis DS, Palmier C, Colpaert FC, Pauwels PJ (1998) Autoradiography of serotonin 5-HT1A receptor-activated G proteins in guinea pig brain sections by agonist-stimulated [35S]GTP\u03b3S binding. J Neurochem 70:1258\u20131268","journal-title":"J Neurochem"},{"key":"41_CR11","doi-asserted-by":"crossref","first-page":"1218","DOI":"10.1021\/jm970457s","volume":"41","author":"LM Gaster","year":"1998","unstructured":"Gaster LM, Blaney FE, Davies S, Duckworth DM, Ham P, Jenkins S, Jennings AJ, Joiner GF, King FD, Mulholland KR, Wyman PA, Hagan JJ, Hatcher J, Jones BJ, Middlemiss DN, Price GW, Riley G, Roberts C, Routledge C, Selkirk J, Slade PD (1998) The selective 5-HT1B receptor inverse agonist 1\u2032-methyl-5-[[2\u2032-methyl-4\u2032-(5-methyl-1,2,4-oxadiazol-3-yl)biphenyl-4-yl]carbonyl]-2,3,6,7-tetrahydrospiro[furo[2,3-f]indole-3,4\u2032-piperidine] (SB-224289) potently blocks terminal 5-HT autoreceptor function both in vitro and in vivo. J Med Chem 41:1218\u20131235","journal-title":"J Med Chem"},{"key":"41_CR12","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0014-2999(97)01115-1","volume":"334","author":"CC Gerhardt","year":"1997","unstructured":"Gerhardt CC, van Heerikhuizen H (1997) Functional characteristics of heterologously expressed 5-HT receptors. Eur J Pharmacol 334:1\u201323","journal-title":"Eur J Pharmacol"},{"key":"41_CR13","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/0166-4328(96)00065-4","volume":"73","author":"MA Geyer","year":"1996","unstructured":"Geyer MA (1996) Serotonergic functions in arousal and motor activity. Behav Brain Res 73:31\u201335","journal-title":"Behav Brain Res"},{"key":"41_CR14","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1016\/1044-7431(92)90070-I","volume":"3","author":"MW Hamblin","year":"1992","unstructured":"Hamblin MW, McGuffin RW, Metcalf MA, Dorsa DM, Merchant KM (1992) Distinct 5-HT1B and 5-HT1D serotonin receptors in rat: structural and pharmacological comparison of the two cloned receptors. Mol Cell Neurosci 3:578\u2013587","journal-title":"Mol Cell Neurosci"},{"key":"41_CR15","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1016\/j.lfs.2003.07.005","volume":"74","author":"C Harrison","year":"2003","unstructured":"Harrison C, Traynor JR (2003) The [35S]GTP\u03b3S binding assay: approaches and applications in pharmacology. Life Sci 74:489\u2013508","journal-title":"Life Sci"},{"key":"41_CR16","first-page":"157","volume":"46","author":"D Hoyer","year":"1994","unstructured":"Hoyer D, Clarke DE, Fozard JR, Hartig PR, Martin GR, Mylecharane EJ, Saxena FR, Humphrey PA (1994) International union of pharmacology classification of receptors for 5-hydroxytryptamine (serotonin). Pharamcol Rev 46:157\u2013203","journal-title":"Pharamcol Rev"},{"key":"41_CR17","doi-asserted-by":"crossref","first-page":"1443","DOI":"10.1111\/j.1476-5381.1996.tb15304.x","volume":"117","author":"GA Kennett","year":"1996","unstructured":"Kennett GA, Bright F, Trail B, Baxter GS, Blackburn TP (1996) Effects of the 5-HT2B receptor agonist, BW723C86, on three rat models of anxiety. Br J Pharmacol 117:1443\u20131448","journal-title":"Br J Pharmacol"},{"key":"41_CR18","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1016\/S0028-3908(96)00171-2","volume":"36","author":"GA Kennett","year":"1997","unstructured":"Kennett GA, Ainsworth K, Trail B, Blackburn TP (1997) BW723C86, a 5-HT2B receptor agonist, causes hyperphagia and reduced grooming in rats. Neuropharmacology 36:233\u2013239","journal-title":"Neuropharmacology"},{"key":"41_CR19","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1002\/ddr.430260305","volume":"26","author":"BK Koe","year":"1992","unstructured":"Koe BK, Nielsen JA, Macor JE, Heym J (1992) Biochemical and behavioral studies of the 5-HT1B receptor agonist, CP-94,253. Drug Develop Res 26:241\u2013250","journal-title":"Drug Develop Res"},{"key":"41_CR20","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/0165-6147(93)90018-F","volume":"14","author":"S Lazareno","year":"1993","unstructured":"Lazareno S, Birdsall NJM (1993) Estimation of antagonist K b from inhibition curves in functional experiments: alternatives to the Cheng-Prusoff equation. Trends Pharmacol Sci 14:237\u2013239","journal-title":"Trends Pharmacol Sci"},{"key":"41_CR21","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1111\/j.1476-5381.1996.tb15982.x","volume":"119","author":"MR MacLean","year":"1996","unstructured":"MacLean MR, Clayton RA, Templeton AGB, Morecroft I (1996) Evidence for 5-HT1-like receptor-mediated vasoconstriction in human pulmonary artery. Br J Pharmacol 119:277\u2013282","journal-title":"Br J Pharmacol"},{"key":"41_CR22","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1016\/S0893-133X(99)00042-1","volume":"21","author":"O Massot","year":"1999","unstructured":"Massot O, Rousselle J-C, Fillion M-P, Januel D, Plantefol M, Fillion G (1999) 5-HT1B receptors: a novel target for lithium. Possible involvement in mood disorders. Neuropsychopharmacology 21:530\u2013541","journal-title":"Neuropsychopharmacology"},{"key":"41_CR23","doi-asserted-by":"crossref","first-page":"1111","DOI":"10.1016\/S0149-7634(99)00067-6","volume":"23","author":"A Meneses","year":"1999","unstructured":"Meneses A (1999) 5-HT system and cognition. Neurosci Biobehav Rev 23:1111\u20131125","journal-title":"Neurosci Biobehav Rev"},{"key":"41_CR24","first-page":"61S","volume":"21","author":"MJ Millan","year":"1999","unstructured":"Millan MJ, Gobert A, Audinot V, Dekeyne A, Newman-Tancredi A (1999) Inverse agonists and serotonergic transmission: from recombinant, human serotonin (5-HT)1B receptors to G-protein coupling and function in corticolimbic structures in vivo. Neuropsychopharmacology 21:61S\u201367S","journal-title":"Neuropsychopharmacology"},{"key":"41_CR25","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1016\/S0091-3057(01)00716-X","volume":"71","author":"MJ Millan","year":"2002","unstructured":"Millan MJ, Newman-Tancredi A, Lochon S, Touzard M, Aubry S, Audinot AV (2002) Specific labelling of serotonin 5-HT1B receptors in rat frontal cortex with the novel, phenylpiperazine derivative, [3H]GR125,743. A pharmacological characterization. Pharmacol Biochem Behav 71:589\u2013598","journal-title":"Pharmacol Biochem Behav"},{"key":"41_CR26","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1016\/S0006-8993(99)01660-1","volume":"836","author":"AL Mize","year":"1999","unstructured":"Mize AL, Alper RH (1999) Serotonin 5-HT1B\/1D agonist-stimulated [35S]GTP\u03b3S binding in rat and guinea pig striatal membranes. Brain Res 836:229\u2013236","journal-title":"Brain Res"},{"key":"41_CR27","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0014-2999(00)00581-1","volume":"404","author":"C Moret","year":"2000","unstructured":"Moret C, Briley M (2000) The possible role of 5-HT1B\/D receptors in psychiatric disorders and their potential as a target for therapy. Eur J Pharmacol 404:1\u201312","journal-title":"Eur J Pharmacol"},{"key":"41_CR28","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1016\/0006-8993(96)00178-3","volume":"722","author":"JF Neumaier","year":"1996","unstructured":"Neumaier JF, Szot P, Peskind ER, Dorsa DM, Hamblin MW (1996) Serotonergic lesioning differentially affects presynaptic and postsynaptic 5-HT1B receptor mRNA levels in rat brain. Brain Res 722:50\u201358","journal-title":"Brain Res"},{"key":"41_CR29","doi-asserted-by":"crossref","first-page":"1042","DOI":"10.1124\/mol.58.5.1042","volume":"58","author":"A Newman-Tancredi","year":"2000","unstructured":"Newman-Tancredi A, Audinot V, Moreira C, Verri\u00e8le L, Millan MJ (2000) Inverse agonism and constitutive activity as functional correlates of serotonin h5-HT1B receptor\/G-protein stoichiometry. Mol Pharmacol 58:1042\u20131049","journal-title":"Mol Pharmacol"},{"key":"41_CR30","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1016\/0922-4106(95)90053-5","volume":"288","author":"Y Odagaki","year":"1995","unstructured":"Odagaki Y, Fuxe K (1995) 5-HT1A receptor-mediated activation of high-affinity GTPase in rat hippocampal membranes. Eur J Pharmacol 288:385\u2013388","journal-title":"Eur J Pharmacol"},{"key":"41_CR31","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1385\/0-89603-495-X:133","volume-title":"Receptor Signal Transduction Protocols, Methods in Molecular Biology, vol 83","author":"Y Odagaki","year":"1997","unstructured":"Odagaki Y, Fuxe K (1997) Agonist-induced high-affinity GTP hydrolysis as an index of receptor-mediated G protein activation in mammalian brain membranes. In: Challis RAJ (ed) Receptor Signal Transduction Protocols, Methods in Molecular Biology, vol 83. Humana Press, Totowa, pp 133\u2013141"},{"key":"41_CR32","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1254\/jphs.FPJ05010X","volume":"98","author":"Y Odagaki","year":"2005","unstructured":"Odagaki Y, Toyoshima R (2005a) Detailed pharmacological characterization of 5-HT1A-receptor-mediated [35S]GTP\u03b3S binding in rat hippocampal membranes. J Pharmacol Sci 98:66\u201376 (Erratum; J Pharmacol Sci 99: 190, 2005)","journal-title":"J Pharmacol Sci"},{"key":"41_CR33","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.ejphar.2005.07.018","volume":"521","author":"Y Odagaki","year":"2005","unstructured":"Odagaki Y, Toyoshima R (2005b) 5-HT1A receptor-mediated G protein activation assessed by [35S]GTP\u03b3S binding in rat cerebral cortex. Eur J Pharmacol 521:49\u201358","journal-title":"Eur J Pharmacol"},{"key":"41_CR34","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1177\/0269881105051526","volume":"19","author":"Y Odagaki","year":"2005","unstructured":"Odagaki Y, Toyoshima R, Yamauchi (2005) Trazodone and its active metabolite m-chlorophenylpiperazine as partial agonists at 5-HT1A receptors assessed by [35S]GTP\u03b3S binding. J Psychopharmacol 19:235\u2013241","journal-title":"J Psychopharmacol"},{"key":"41_CR35","first-page":"938","volume":"270","author":"PJ Pauwels","year":"1994","unstructured":"Pauwels PJ, Palmier C (1994) Differential functional activity of 5-hydroxytryptamine receptor ligands and beta adrenergic receptor antagonists at 5-hydroxytryptamine1B receptor sites in Chinese hamster lung fibroblasts and opossum renal epithelial cells. J Pharmacol Exp Ther 270:938\u2013945","journal-title":"J Pharmacol Exp Ther"},{"key":"41_CR36","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1016\/S0028-3908(96)00170-0","volume":"36","author":"PJ Pauwels","year":"1997","unstructured":"Pauwels PJ, Tardif S, Palmier C, Wurch T, Colpaert FC (1997a) How efficacious are 5-HT1B\/D receptor ligands: an answer from GTP\u03b3S binding studied with stably transfected C6-glioma cell lines. Neuropharmacology 36:499\u2013512","journal-title":"Neuropharmacology"},{"key":"41_CR37","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1007\/PL00005090","volume":"356","author":"PJ Pauwels","year":"1997","unstructured":"Pauwels PJ, Tardif S, Wurch T, Colpaert C (1997b) Stimulated [35S]GTP\u03b3S binding by 5-HT1A receptor agonists in recombinant cell lines. Modulation of apparent efficacy by G-protein activation state. Naunyn-Schmiedeberg\u2019s Arch Pharmacol 356:551\u2013561","journal-title":"Naunyn-Schmiedeberg\u2019s Arch Pharmacol"},{"key":"41_CR38","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1007\/PL00005056","volume":"356","author":"GW Price","year":"1997","unstructured":"Price GW, Burton MJ, Collin LJ, Duckworth M, Gaster L, G\u00f6thert M, Jones BJ, Roberts C, Watson JM, Middlemiss DN (1997) SB-216641 and BRL-15572 \u2014 compounds to pharmacologically discriminate h5-HT1B and h5-HT1D receptors. Naunyn-Schmiedeberg\u2019s Arch Pharmacol 356:312\u2013320","journal-title":"Naunyn-Schmiedeberg\u2019s Arch Pharmacol"},{"key":"41_CR39","doi-asserted-by":"crossref","first-page":"899","DOI":"10.1016\/S0306-4522(98)00256-5","volume":"88","author":"Y Sari","year":"1999","unstructured":"Sari Y, Miquel M-C, Brisorgueil M-J, Ruiz G, Doucet E, Hamon M, Verg\u00e9Verri\u00e8le D (1999) Cellular and subcellular localization of 5-hydroxytryptamine1B receptors in the rat central nervous system: immunocytochemical, autoradiographic and lesion studies. Neuroscience 88:899\u2013915","journal-title":"Neuroscience"},{"key":"41_CR40","doi-asserted-by":"crossref","first-page":"1875","DOI":"10.1126\/science.8091214","volume":"265","author":"F Saudou","year":"1994","unstructured":"Saudou F, Amara DA, Dierich A, LeMeur M, Ramboz S, Segu L, Buhot M-C, Hen R (1994) Enhanced aggressive behavior in mice lacking 5-HT1B receptor. Science 265:1875\u20131878","journal-title":"Science"},{"key":"41_CR41","doi-asserted-by":"crossref","first-page":"732","DOI":"10.1111\/j.1476-5381.1992.tb09047.x","volume":"105","author":"E Schlicker","year":"1992","unstructured":"Schlicker E, Werner U, Hamon M, Gozlan H, Nickel B, Szelenyi I, G\u00f6thert M (1992) Anpirtoline, a novel, highly potent 5-HT1B receptor agonist with antinocicetive\/antidepressant-like actions in rodents. Br J Pharmacol 105:732\u2013738","journal-title":"Br J Pharmacol"},{"key":"41_CR42","doi-asserted-by":"crossref","first-page":"602","DOI":"10.1007\/BF00175784","volume":"337","author":"P Schoeffter","year":"1988","unstructured":"Schoeffter P, Waeber C, Palacios JM, Hoyer D (1988) The 5-hydroxytryptamine 5-HT1D receptor subtype is negatively coupled to adenylate cyclase in calf substantia nigra. Naunyn-Schmiedeberg\u2019s Arch Pharmacol 337:602\u2013608","journal-title":"Naunyn-Schmiedeberg\u2019s Arch Pharmacol"},{"key":"41_CR43","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1007\/s00210-002-0588-0","volume":"366","author":"R Seifert","year":"2002","unstructured":"Seifert R, Wenzel-Seifert K (2002) Constitutive activity of G-protein-coupled receptors: cause of disease and common property of wild-type receptors. Naunyn-Schmiedeberg\u2019s Arch Pharmacol 366:381\u2013416","journal-title":"Naunyn-Schmiedeberg\u2019s Arch Pharmacol"},{"key":"41_CR44","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1016\/S0028-3908(97)00057-9","volume":"36","author":"SL Shepherd","year":"1997","unstructured":"Shepherd SL, Williamson DJ, Beer MS, Hill RG, Hargreaves RJ (1997) Differential effects of 5-HT1B\/1D receptor agonists on neurogenic dural plasma extravasation and vasodilation in anaesthetized rats. Neuropharmacology 36:525\u2013533","journal-title":"Neuropharmacology"},{"key":"41_CR45","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1177\/026988119400800103","volume":"8","author":"M Skingle","year":"1994","unstructured":"Skingle M, Higgins GA, Feniuk W (1994) Stimulation of central 5-HT1D receptors causes hypothermia in the guinea-pig. J Psychopharmacol 8:14\u201321","journal-title":"J Psychopharmacol"},{"key":"41_CR46","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/0166-4328(96)00089-7","volume":"73","author":"M Skingle","year":"1996","unstructured":"Skingle M, Beattie DT, Scopes DIC, Starkey SJ, Conner HE, Feniuk W, Tyers MB (1996) GR127935: a potent and selective 5-HT1D receptor antagonist. Behav Brain Res 73:157\u2013161","journal-title":"Behav Brain Res"},{"key":"41_CR47","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/S0165-0173(01)00106-0","volume":"38","author":"J S\u00f3v\u00e1g\u00f3","year":"2001","unstructured":"S\u00f3v\u00e1g\u00f3 J, Dupuis DS, Guly\u00e1s B, Hall H (2001) An overview on functional receptor autoradiography using [35S]GTP\u03b3S. Brain Res Rev 38:149\u2013164","journal-title":"Brain Res Rev"},{"key":"41_CR48","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1124\/mol.52.4.623","volume":"52","author":"C Waeber","year":"1997","unstructured":"Waeber C, Moskowitz HA (1997) 5-Hydroxytryptamine1A and 5-hydroxytryptamine1B receptors stimulate [35S]guanosine-5\u2032-O-(3-thio)triphosphate binding to rodent brain sections as visualized by in vitro autoradiography. Mol Pharmacol 52:623\u2013631","journal-title":"Mol Pharmacol"},{"key":"41_CR49","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/0014-2999(95)00612-1","volume":"287","author":"DM Walsh","year":"1995","unstructured":"Walsh DM, Beattie DT, Connor HE (1995) The activity of 5-HT1D receptor ligands at cloned human % MathType!Translator!2!1!AMS LaTeX.tdl!TeX -- AMS-LaTeX! % MathType!MTEF!2!1!+- % feaaeaart1ev0aaatCvAUfeBSjuyZL2yd9gzLbvyNv2CaerbbjxAHX % garmWu51MyVXgatuuDJXwAK1uy0HwmaeHbfv3ySLgzG0uy0Hgip5wz % aebbnrfifHhDYfgasaacH8qrps0lbbf9q8WrFfeuY-Hhbbf9v8qqaq % Fr0xc9pk0xbba9q8WqFfea0-yr0RYxir-Jbba9q8aq0-yq-He9q8qq % Q8frFve9Fve9Ff0dmeaabaqaciGacaGaaeqabaWaaeWaeaaakeaaca % qG1aGaaeylaiaabIeacaqGubWaaSbaaSqaaiaabgdacaqGebGaeqyS % degabeaaaaa!3DE0! $${\\text{5 - HT}}_{{{\\text{1D}}\\alpha }}$$ and % MathType!Translator!2!1!AMS LaTeX.tdl!TeX -- AMS-LaTeX! % MathType!MTEF!2!1!+- % feaaeaart1ev0aaatCvAUfeBSjuyZL2yd9gzLbvyNv2CaerbbjxAHX % garmWu51MyVXgatuuDJXwAK1uy0HwmaeHbfv3ySLgzG0uy0Hgip5wz % aebbnrfifHhDYfgasaacH8qrps0lbbf9q8WrFfeuY-Hhbbf9v8qqaq % Fr0xc9pk0xbba9q8WqFfea0-yr0RYxir-Jbba9q8aq0-yq-He9q8qq % Q8frFve9Fve9Ff0dmeaabaqaciGacaGaaeqabaWaaeWaeaaakeaaca % qG1aGaaeylaiaabIeacaqGubWaaSbaaSqaaiaabgdacaqGebGaaeOS % daqabaaaaa!3D79! $${\\text{5 - HT}}_{{{\\text{1D $\\beta $ }}}}$$ receptors. Eur J Pharmacol 287:79\u201384","journal-title":"Eur J Pharmacol"}],"container-title":["Naunyn-Schmiedeberg's Archives of Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00210-006-0041-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00210-006-0041-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00210-006-0041-x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,23]],"date-time":"2019-05-23T20:02:05Z","timestamp":1558641725000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00210-006-0041-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,2]]},"references-count":49,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2006,2]]}},"alternative-id":["41"],"URL":"https:\/\/doi.org\/10.1007\/s00210-006-0041-x","relation":{},"ISSN":["0028-1298","1432-1912"],"issn-type":[{"value":"0028-1298","type":"print"},{"value":"1432-1912","type":"electronic"}],"subject":[],"published":{"date-parts":[[2006,2]]}}}